-
Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1
SAN DIEGO, June 12, 2026 (GLOBE NEWSWIRE) — Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio®” or the “Company”), a
Lifestyle Content
Technology
-
MM400: A Rising Force Bridging Music, Film, and Galactic Vision
-
DREA DOMINIQUE SOARS WITH LATEST SINGLE ‘LUE VITON’ ON ALL MAJOR STREAMING PLATFORMS
-
The Pocket Gods Release Final Protest Single “The Sound of Silence (SOS)” as £1 Million Album Campaign Heads to Raindance Film Festival Premiere
-
Randy Edelman Announces New Album Green Park
-
Arsenic Kitchen Announces Highly Anticipated Hometown Show at Phoenix’s Iconic Rebel Lounge on July 10th
Entertainment
-
Global Aerospace’s Annual Jetstream Publication Provides An Introduction to Litigation Funding
-
Filthy to Fresh Car Valeting Expands Mobile Car Valeting Services Across Worcestershire & Surrounding Towns
-
Product Air Earns Elite Diamond Status: Mitsubishi Recognizes Company in Highest Category Held by Fewer Than 5% of Contractors Nationwide
-
Next Gen Contracting Expands Presence With Newly Opened Medford Office
-
Ryan’s Home Services Reaches Major Milestone with 32,000 Completed Work Orders
